ATEX - Company ID 0001304492
The table below shows Anterix Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.57M | $1.55M | $1.42M | $1.57M | $1.55M | $1.52M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $1.10M | $1.21M | $1.12M | $1.12M | $1.78M | $1.75M |
Anterix Inc. reported annual revenue of $6.03M for fiscal year 2025. That is up 43.9% from $4.19M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $3.54M (FY 2016) to $6.03M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $8.66M |
| $8.40M |
| $10.45M |
| $9.20M |
| $11.40M |
| $12.85M |
| Operating income | -$9.06M | $60.67M | $22.48M | $7.03M | -$13.13M | -$15.01M |
| Income tax | -$2.05M | $7.52M | -$2.26M | -$234.00K | $230.00K | $1.22M |
| Net income | -$6.60M | $53.54M | $25.18M | $7.71M | -$12.77M | -$15.52M |
| EPS (diluted) | -$0.35 | $2.86 | $1.35 | $0.41 | -$0.69 | -$0.84 |